In vitro detection of contact allergens: development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells.

Allergic contact dermatitis is a delayed T-cell mediated allergic response associated with relevant social and economic impacts. Animal experiments (e.g. the local lymph node assay) are still supplying most of the data used to assess the sensitization potential of new chemicals. However, the 7th amendment to the EU Cosmetic Directive will introduce a testing ban for cosmetic ingredients after 2013. In vitro alternative methods are thus being actively developed. Although promising results have been obtained with cell lines, their reduced functionality and inherent genomic instability led us to reinvestigate the use of peripheral blood monocyte-derived dendritic cells (PBMDCs) for the establishment of a reliable in vitro sensitization test. To solve the issues associated with the use of primary cells, the culture and exposure conditions (cytokine concentrations, incubation time, readout, pooled vs. single donors and cytotoxicity) were re-assessed and optimized. Here we propose a stable and reproducible protocol based on PBMDCs. This should allow a wider acceptance of PBMDCs as a reliable test system for the detection of human skin sensitizers and the inclusion of this protocol in an integrated testing strategy.

[1]  G F Gerberick,et al.  Local lymph node assay: differentiating allergic and irritant responses using flow cytometry. , 1999, Methods.

[2]  Silvia Martinozzi-Teissier,et al.  Activation of U937 Cells by Contact Sensitizers: CD86 Expression is Independent of Apoptosis , 2006, Journal of immunotoxicology.

[3]  I. Fabre,et al.  The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. , 2006, Toxicology and applied pharmacology.

[4]  P. Matzinger,et al.  Danger signals: SOS to the immune system. , 2001, Current opinion in immunology.

[5]  H. Wichmann,et al.  Epidemiology of contact allergy in adults , 2001, Allergy.

[6]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[7]  J Hilton,et al.  Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. , 1996, Toxicology.

[8]  D. Schmitt,et al.  Moderate skin sensitizers can induce phenotypic changes on in vitro generated dendritic cells. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  R J Fielder,et al.  Local lymph node assay - validation, conduct and use in practice. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[10]  John P. Moore,et al.  Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical Tissue , 2004, The Journal of experimental medicine.

[11]  J Hilton,et al.  An international evaluation of the murine local lymph node assay and comparison of modified procedures. , 1995, Toxicology.

[12]  S. Spiekstra,et al.  Comparison of a novel CXCL12/CCL5 dependent migration assay with CXCL8 secretion and CD86 expression for distinguishing sensitizers from non-sensitizers using MUTZ-3 Langerhans cells. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[13]  J Hilton,et al.  Assessment of the skin sensitization potential of topical medicaments using the local lymph node assay: an interlaboratory evaluation. , 1998, Journal of toxicology and environmental health. Part A.

[14]  C. Goebel,et al.  Comparative DNA microarray analysis of human monocyte derived dendritic cells and MUTZ-3 cells exposed to the moderate skin sensitizer cinnamaldehyde. , 2009, Toxicology and applied pharmacology.

[15]  I Schmid,et al.  Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. , 1992, Cytometry.

[16]  Frank O. Nestle,et al.  Skin immune sentinels in health and disease , 2009, Nature Reviews Immunology.

[17]  Ian Kimber,et al.  The suitability of hexyl cinnamic aldehyde as a calibrant for the murine local lymph node assay , 2001, Contact dermatitis.

[18]  D. Basketter,et al.  The performance of the local lymph node assay with chemicals identified as contact allergens in the human maximization test. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  L H Kligman,et al.  In vitro model for contact sensitization: I. Stimulatory capacities of human blood-derived dendritic cells and their phenotypical alterations in the presence of contact sensitizers. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  Kwang Dong Kim,et al.  Impaired responses of leukemic dendritic cells derived from a human myeloid cell line to LPS stimulation , 2006, Experimental & Molecular Medicine.

[21]  D. Basketter,et al.  In vitro approaches to the identification and characterization of skin sensitizers. , 2013, Cutaneous and ocular toxicology.

[22]  I Kimber,et al.  Local lymph node assay: validation assessment for regulatory purposes. , 2000, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[23]  K. Miyazono,et al.  Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin , 1989, Journal of cellular physiology.

[24]  C. Borrebaeck,et al.  Functional and transcriptional profiling of MUTZ‐3, a myeloid cell line acting as a model for dendritic cells , 2006, Immunology.

[25]  D A Basketter,et al.  Comparison of the local lymph node assay with the guinea-pig maximization test for the detection of a range of contact allergens. , 1992, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[26]  I Kimber,et al.  The local lymph node assay: developments and applications. , 1994, Toxicology.

[27]  T. Bieber,et al.  Dendritic cells in allergy , 1999, Allergy.

[28]  D. Jäger,et al.  In vitro model for contact sensitization: II. Induction of IL-1beta mRNA in human blood-derived dendritic cells by contact sensitizers. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.

[29]  Ian Kimber,et al.  Local Lymph Node Assays , 2004, Current protocols in toxicology.

[30]  Carsten Goebel,et al.  Assessment of the U937 cell line for the detection of contact allergens. , 2007, Toxicology and applied pharmacology.

[31]  Takao Ashikaga,et al.  Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[32]  D. Basketter,et al.  Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde. , 1998, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[33]  D. Basketter,et al.  Local lymph node assay: use in hazard and risk assessment , 1999, Journal of applied toxicology : JAT.

[34]  S. Gibbs,et al.  Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. , 2009, Toxicology and applied pharmacology.

[35]  Ian Kimber,et al.  The local lymph node assay: past, present and future , 2002, Contact dermatitis.

[36]  C. Goebel,et al.  Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. , 2004, The Journal of investigative dermatology.

[37]  O. Majdic,et al.  Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. , 1996, Journal of immunology.

[38]  Susan Gibbs,et al.  Dendritic cells: biology of the skin , 2009, Contact dermatitis.

[39]  I Kimber,et al.  Human potency predictions for aldehydes using the local lymph node assay , 2001, Contact dermatitis.

[40]  I. Nelissen,et al.  MUTZ-3-derived dendritic cells as an in vitro alternative model to CD34+ progenitor-derived dendritic cells for testing of chemical sensitizers. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[41]  S. Aiba,et al.  Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co‐stimulatory molecules , 1997, European journal of immunology.

[42]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.